HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis

被引：0
|
作者：
Maria Bucova
Beata Majernikova
Vladimira Durmanova
Daniela Cudrakova
Karin Gmitterova
Iveta Lisa
Eleonora Klimova
Kristina Kluckova
Milan Buc
机构：
[1] Comenius University,Institute of Immunology, Faculty of Medicine
[2] Comenius University and University Hospital,1st. Department of Neurology, Faculty of Medicine
[3] Comenius University,2nd Department of Neurology, Faculty of Medicine
[4] Faculty Hospital of JA Raiman,Centre for Therapy and Diagnosis of Multiple Sclerosis
来源：
Neurological Sciences | 2020年 / 41卷
关键词：
HMGB1; Immunity; Inflammation; Multiple sclerosis; EDSS; MSSS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：599 / 604
页数：5
相关论文
共 50 条
  • [21] Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis
    Sunny Malhotra
    Nicolas Fissolo
    Mar Tintoré
    Ana Cristina Wing
    Joaquin Castilló
    Angela Vidal-Jordana
    Xavier Montalban
    Manuel Comabella
    Journal of Neuroinflammation, 12
  • [22] The release and activity of HMGB1 in ferroptosis
    Wen, Qirong
    Liu, Jiao
    Kang, Rui
    Zhou, Borong
    Tang, Daolin
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 510 (02) : 278 - 283
  • [23] Targeting HMGB1: A Potential Therapeutic Strategy for Chronic Kidney Disease
    Liu, Tongtong
    Li, Qian
    Jin, Qi
    Yang, Liping
    Mao, Huimin
    Qu, Peng
    Guo, Jing
    Zhang, Bo
    Ma, Fang
    Wang, Yuyang
    Peng, Liang
    Li, Ping
    Zhan, Yongli
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2023, 19 (15): : 5020 - 5035
  • [24] HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson’s Disease
    Yu Tian
    Rong Chen
    Zhaoliang Su
    Cellular and Molecular Neurobiology, 2023, 43 : 47 - 58
  • [25] Investigation of HMGB1 as a potential marker for radiation response in muscle invasive bladder cancer
    Mansure, Jose J.
    Shrivastava, Sanhita
    Nassim, Roland
    Ferbeyre, Gerardo
    Kassouf, Wassim
    CANCER RESEARCH, 2014, 74 (19)
  • [26] HMGB1 is a Potential and Challenging Therapeutic Target for Parkinson's Disease
    Tian, Yu
    Chen, Rong
    Su, Zhaoliang
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2023, 43 (01) : 47 - 58
  • [27] Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis
    Kaplan, B.
    Golderman, S.
    Ganelin-Cohen, E.
    Miniovitch, A.
    Korf, E.
    Ben-Zvi, I.
    Livneh, A.
    Flechter, S.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 192 (01): : 7 - 17
  • [28] Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis
    Andersson, Asa
    Covacu, Ruxandra
    Sunnemark, Dan
    Danilov, Alexandre I.
    Dal Bianco, Assunta
    Khademi, Mohsen
    Wallstrom, Erik
    Lobell, Anna
    Brundin, Lou
    Lassmann, Hans
    Harris, Robert A.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (05) : 1248 - 1255
  • [29] HMGB1 as a therapeutic target in disease
    Xue, Jiaming
    Suarez, Joelle S.
    Minaai, Michael
    Li, Shuangjing
    Gaudino, Giovanni
    Pass, Harvey I.
    Carbone, Michele
    Yang, Haining
    JOURNAL OF CELLULAR PHYSIOLOGY, 2021, 236 (05) : 3406 - 3419
  • [30] SIRT1 as a potential marker of disease activity and response to treatment with Glatiramer Acetate in multiple sclerosis.
    Hewes, Daniel
    Tatomir, Alexandru
    Kruszewski, Adam M.
    Criello, Jonathan
    Rao, Gautam K.
    Royal, Walter, III
    Bever, Christopher T.
    Rus, Horea
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 14 - 14
12345